14:15 – 14:30
16.11.2021

The lecture gives an introduction and overview on the topics and speakers of the session. It will outline the great opportunity of liquid biopsy diagnostics in oncology that is mirrored by new research results and experiences with implementing liquid profiling into standard care. Further it will point to stratification and monitoring strategies of new immune therapies in cancer patients by conventional and molecular lab diagnostics. Finally it will present exosomal RNA markers as "new kids on the block" of cancer diagnostics.